Effects of zearalenone and α-zearalenol in comparison with raloxifene on T47D cells

Toxicology Mechanisms and Methods

Volumn 19, Issue 3, 2009, Pages 246-250

  Khosrokhavar, Roya ^a   Rahimifard, Nahid ^a   Shoeibi, Shahram ^a   Hamedani, Morteza Pirali ^a,b   Hosseini, Mir Jamal ^c  

^a MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Zearalenol; Breast cancer; Estrogenic activity; Raloxifene; Zearalenone

Indexed keywords

ALPHA ZEARALENOL; RALOXIFENE; ZEARALENONE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN MDA MB 231; CELL STRAIN T47D; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE TECHNIQUE; DIET; DRUG EFFECT; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

BONE DENSITY CONSERVATION AGENTS; CELL LINE, TUMOR; HUMANS; MYCOTOXINS; RALOXIFENE; ZEARALENONE; ZERANOL;

EID: 69249165888     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.1080/15376510802455347     Document Type: Article

References (30)

1. Baldwin, R. S., Williams, R. D., and Terry, M. K. 1983. Zeranol: a review of the metabolism, toxicology and analytical methods for detection of tissue residues. Regul. Toxicol. Pharmacol. 3:9-25.
2. Barnes, S. 1998. Phytoestrogens and breast cancer. Baillieres Clin. Endocrinol. Metab. 12:559-579.
3. Barrett-connor, E. 2001. Raloxifene: risks and benefits. Ann. N. Y. Acad. Sci. 949:295-303.
4. Bennet, G. A., and Shotwel, O. L. 1979. Zearalenone in cereals grains. J. Am. Oil Chem. Soc. 56:812-819.
5. Chang, K., Kurtz, J. H., and Mirocha, C. J. 1979. Effects of mycotoxin zearalenone on swine reproduction. Am. J. Vet. Res. 40:1260-1267.
6. Clarke, R., Hilaviki-Clarke, L., and Trock, B. 2001. Breast cancer: dietary and environmental oestrogens. Biologist (Lond.) 48:21-26.
7. Dees, C., Foster, J. S., Ahamad, S., and Wimalasena, J. 1997. Dietary estrogens stimulate human breast cells to enter the cell cycle. Environ. Health Perspect. 105:633-636. (Pubitemid 27246428)
8. Erasmuson, A. F., Scahill, B. G., and West, D. M. 1994. Natural zeranol (α-zearalenol) in the urine of pasture-fed animals. J. Agr. Food Chem. 42:2721-2725.
9. Etienne, M., and Jemmali, M. 1982. Effects of zearalenone (F2) on estrous activity and reproduction in gilts. J. Anim. Sci. 55:1-10.
10. Gareis, M., Bauer, J., Enders, C., and Gedek, B. 1989. In: Chelkowski, J. (Ed.), Topics in Secondary Metabolism: Fusarium mycotoxins, taxonomy, pathogenicity, Elsevier, Warsaw, Poland. p. 441.
11. Hertz, R. 1985. The estrogen problem-retrospect and prospect. In: McLachlan, J. A. (Ed.), Estrogens in the Environment II-Influences on Development, Elsevier, New York, pp. 1-11.
12. Key, T. J., Verkasalo, P. K., and Banks, E. 2001. Epidemiology of breast cancer. Lancet Oncol. 2:133-140.
13. Kiessling, K. H., and Pattersson, H. 1978. Metabolism of zearalenone in rat liver. Acta Pharmacol. Toxicol. 47:285-290.
14. Kim, H. T., Kim, B. C., Kim, I. Y., Mamura, M., Seong, D. H., Jang, J., and Kim, S. 2002. Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis through cleavage of BAD in TSU-PR1 human cancer cells. J. Biol. Chem. 277:32510-32515. (Pubitemid 34984754)
15. Kuiper-Goodman, T., Scott, P. M., and Watanabe, H. 1987. Risk assessment of mycotoxin zearalenone. Regul. Toxicol. Pharmacol. 7:253-306.
16. Kurzer, M. S., and Xu, X. 1997. Dietary phytoestrogens. Annu. Rev. Nutr. 17:353-381.
17. Lacey, Jr. J. V., Devesa, S. S., and Brinton, L. A. 2002. Recent trends in breast cancer incidence and mortality. Epidemiol. Mol. Mutagen. 39:82-88.
18. Makela, S., and Davis, V. L. 1994. Dietary estrogens act through estrogen receptor-mediated process and show no antiestrogenicity in cultured breast cancer cells. Environ. Health Perspect. 102:572-579.
19. Martin, P. M., Horwiz, K. B., Ryan, D. S., and McGuire, W. L. 1978. Phytoestrogen interaction with estrogen receptor in human breast cancer cells. Endocrinology 103:1860-1867.
20. Mirocha, C. J., Pathre, S. V., and Robinson, T. S. 1981. Comparative metabolism of zearalenone and transmission into bovine milk. Food Cosmet. Toxicol. 19:25-30.
21. Richardson, K. E., Hagler, W. M., and Mirocha, J. 1985. Production of zearalenone, alpha- and beta-zearalenol by Fusarium spp. in rice J. Agric. Food Chem. 33:862-866.
22. Safe, S. H. 1997. Is there an association between exposure to environmental estrogens and breast cancer? Environ. Health Perspect. 105:675-678.
23. Schoental, R. 1974. Role of podophyllotoxin in the bedding and dietary zearalenone on incidence of spontaneous tumors in laboratory animals [letter]. Cancer Res. 34:2419-2420.
24. Sutton, J. C., Balik, W., and Funnett, H. S. 1980. Relation of weather variable to incidence of zearalenone in corn in Southern Ontario. Can. J. Lant. Sci. 60:149-155.
25. Tanak, T., Hasegawa, A., Ymamoto, S., Lee, U. S., Sugiura, Y., and Ueno, Y. 1988. Worldwide contamination of cereals by the Fusarium mycotoxins nivalenol, deoxynivalenol, and zearalenone. J. Agric. Food Chem. 36:979-983.
26. Tomaszewski, J., Miturski, R., Semczuk, A., Kotarski, J., and Jakowicki, J. 1998. [Tissue zearalenone concentration in normal, hyperplastic and neoplastic human endometrium]. Ginekol. Pol. 69:363-366.
27. Trenholm, H. L., Thompson, B. K., Standish, J. F., and Seamen, W. L. 1985. Mycotoxins in feeds and feedstuffs. In: Scott, P. M., Trenholm, H. L. and Sutton, M. D. (Eds.), Mycotoxins, A Canadian Perspective, National Research Council of Canada, Ottawa, Ontario, pp. 43-49.
28. Veldman, A., Borggreve, G. J., Mulders, E. J., and Van de Lagemaat, D. 1992. Occurrence of the mycotoxins ochratoxin A, zearalenone and deoxynivalenol in feed components. Food Addit. Contam. 9:647-655.
29. Withanage, G. S., Murata, H., Koyama, T., and Ishiwata, I. 2001. Agonistic and antagonistic effect of zearalenone, an estrogenic mycotoxin, on SKN, HHUA, and HepG2 human cancer cell lines. Vet. Hum. Toxicol. 43:6-10.
30. Zava, D. T., Blen, M., and Duwe, G. 1997. Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture. Environ. Health Perspect. 105:637-645.